Purpose of Therapeutic Phlebotomy: This procedure involves the controlled removal of a specific volume of blood to reduce elevated levels of certain blood components, such as iron, red blood cells, or porphyrins.
Primary Conditions Treated: It is a cornerstone treatment for conditions like hemochromatosis (iron overload), polycythemia vera (excessive red blood cell production), and porphyria cutanea tarda (a disorder affecting skin and liver).
Mechanism of Action: By removing blood, the body is stimulated to produce new blood cells, which in turn utilizes stored iron or reduces the overall red blood cell mass, alleviating symptoms and preventing organ damage.
Not a Blood Donation: While similar in technique, therapeutic phlebotomy is a medical treatment, and the collected blood is typically discarded unless specific protocols for donor eligibility are met.
🤒 Associated Symptoms
Hemochromatosis Indications: Persistent fatigue, joint pain (especially in hands), abdominal pain, liver enlargement, skin bronzing, and cardiac issues, often linked to elevated ferritin and transferrin saturation.
Polycythemia Vera Indications: Headaches, dizziness, blurred vision, tinnitus, pruritus (especially after bathing), erythromelalgia (burning pain in hands/feet), and an enlarged spleen, associated with high hemoglobin and hematocrit.
Porphyria Cutanea Tarda Indications: Fragile skin, blistering lesions, increased hair growth (hirsutism), and hyperpigmentation, particularly in sun-exposed areas, due to porphyrin accumulation.
General Overload Symptoms: Non-specific symptoms like lethargy, weakness, and organ dysfunction can prompt investigation leading to a diagnosis requiring phlebotomy.
🛡 Crucial Precautions
Pre-Procedure Hydration: Patients must be well-hydrated before the procedure to minimize the risk of hypotension and vasovagal reactions.
Medication Review: A thorough review of current medications, especially anticoagulants or antiplatelet agents, is essential due to potential increased bleeding risk at the venipuncture site.
Monitoring for Adverse Reactions: Close observation for signs of dizziness, lightheadedness, pallor, sweating, or syncope during and immediately after the procedure is critical.
Contraindications: Therapeutic phlebotomy is generally contraindicated in patients with severe anemia, active infection, significant cardiovascular instability, or very low blood pressure.
Post-Procedure Activity: Advise patients to avoid strenuous physical activity, heavy lifting, and prolonged standing for at least 24 hours post-procedure.
🍽 Dietary Directions & Restrictions
Pre-Procedure Fluid Intake: Encourage ample fluid intake (water, clear juices) in the 24 hours leading up to the procedure to ensure adequate hydration and venous access.
Avoid Alcohol: Patients should refrain from alcohol consumption for at least 24 hours before and after the procedure, as it can contribute to dehydration and affect blood pressure.
Iron Management (Hemochromatosis): For hemochromatosis, long-term dietary advice may include avoiding iron-fortified foods, iron supplements, and excessive vitamin C intake with iron-rich meals, as vitamin C enhances iron absorption.
Post-Procedure Replenishment: Advise patients to continue hydrating and consume a light, balanced meal after the procedure to aid recovery and prevent post-phlebotomy fatigue.
⚠️ Attendant Guidelines
Patient Identification and Consent: Verify patient identity and confirm informed consent for the therapeutic phlebotomy procedure.
Vital Sign Monitoring: Obtain baseline vital signs (blood pressure, heart rate, respiratory rate) before, during, and after the procedure, and monitor for any significant changes.
Venipuncture Site Care: Ensure strict aseptic technique during venipuncture and apply firm pressure to the site for at least 5-10 minutes post-procedure to prevent hematoma formation.
Volume and Rate Control: Adhere strictly to the prescribed volume of blood to be removed and monitor the flow rate to ensure patient tolerance.
Post-Procedure Observation: Keep the patient under observation for at least 15-30 minutes after the procedure to monitor for delayed adverse reactions.
🩺 Physician's Perspective
Accurate Diagnosis is Key: Confirming the underlying condition (e.g., genetic hemochromatosis, JAK2 mutation for PV) is paramount before initiating therapeutic phlebotomy.
Individualized Treatment Plan: The frequency and volume of blood removal must be tailored to the patient's specific condition, symptoms, and laboratory parameters (e.g., ferritin, hematocrit).
Regular Laboratory Monitoring: Consistent monitoring of relevant blood tests is crucial to guide therapy, prevent over-treatment (e.g., iron deficiency anemia), and assess treatment efficacy.
Patient Education on Adherence: Emphasize the long-term nature of treatment for chronic conditions and the importance of adherence to the phlebotomy schedule and dietary recommendations.
Management of Complications: Be prepared to manage potential complications such as severe vasovagal reactions, persistent hypotension, or significant anemia.
🎓 Academic & Nursing Corner
Sterile Technique Mastery: Proficiency in maintaining a sterile field and performing venipuncture safely and efficiently is fundamental for therapeutic phlebotomy.
Patient Assessment Skills: Develop strong assessment skills to evaluate patient hydration status, vein suitability, and identify early signs of adverse reactions.
Equipment Familiarity: Understand the components of a therapeutic phlebotomy kit, including blood collection bags, tubing, and needles, and their proper use.
Documentation Accuracy: Meticulously document the date, time, volume of blood removed, patient tolerance, vital signs, and any adverse events.
Patient Education Role: Educate patients on pre-procedure preparation, what to expect during the procedure, and post-procedure care, including signs of complications to report.
CPT Code: 99195 (Phlebotomy, therapeutic, for disease other than polycythemia vera; e.g., hemochromatosis). Note: For polycythemia vera, it's often included in office visit codes or specific hospital codes depending on setting.
Key Laboratory Parameters: Ferritin, Transferrin Saturation, Hemoglobin, Hematocrit, Red Blood Cell Count, Liver Function Tests, Porphyrin levels (for PCT).
Clinical Guidelines: Refer to guidelines from organizations like the American Association for the Study of Liver Diseases (AASLD) for hemochromatosis or the National Comprehensive Cancer Network (NCCN) for myeloproliferative neoplasms like polycythemia vera.